The rate of primary hypothyroidism in diabetic patients is greater than in the non-diabetic population. An observational study

被引:36
作者
Tamez-Perez, Hector-Eloy [1 ]
Martinez, Esteban [2 ]
Quintanilla-Flores, Dania L. [1 ]
Tamez-Pena, Alejandra L. [1 ]
Gutierrez-Hermosillo, Hugo [2 ]
Diaz de Leon-Gonzalez, Enrique [2 ]
机构
[1] UANL, Fac Med, Subdirecc Invest, Monterrey, NL, Mexico
[2] Clin Nova, Dept Med Interna, Monterrey, NL, Mexico
来源
MEDICINA CLINICA | 2012年 / 138卷 / 11期
关键词
Type 2 diabetes mellitus; Primary hypothyroidism; Cardiovascular risk;
D O I
10.1016/j.medcli.2011.08.009
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background and objective: The aim of our study was to identify the rate of diabetic patients treated for hypothyroidism and compare them with a group without type 2 diabetes mellitus (T2DM). Patients and methods: We reviewed the computerized clinical records of 5161 patients. We identified diabetic patients treated with L-thyroxine. We compared the prevalence of PH with those patients under treatment with levothyroxine without T2DM. We excluded patients with a thyroid neoplasia, thyroid surgery, panhypopituitarism, or surgical complications of multinodular goiter or a thyroid nodule. Subclinical hypothyroidism was not considered. Results: We included 1848 adult patients with T2DM in the study group, 58% women and 42% men. For the control group, we included 3313 non-diabetic patients, 55% women and 45% men. The mean age in the study group was 52 +/- 7 years, and 47 +/- 4 years in the control group (p < .001). The rate of hypothyroidism in the study group was 5.7%, and in the control group 1.8% (odds ratio of 3.45; 95% confidence interval 2.51-4.79) (p < .001). Conclusion: A strong association between T2DM and hypothyroidism was found. We recommend a thyroid profile in all patients with T2DM, similar to the recommendation in type 1 diabetes mellitus. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:475 / 477
页数:3
相关论文
共 10 条
[1]
Standards of Medical Care in Diabetes-2010 [J].
不详 .
DIABETES CARE, 2010, 33 :S11-S61
[2]
Arroyo-Bros J, 2011, Medicina Clinica, V136, P207
[3]
The interface between thyroid and diabetes mellitus [J].
Duntas, Leonidas H. ;
Orgiazzi, Jacques ;
Brabant, Georg .
CLINICAL ENDOCRINOLOGY, 2011, 75 (01) :1-9
[4]
Thyroid Disorders and Diabetes Mellitus [J].
Hage, Mirella ;
Zantout, Mira S. ;
Azar, Sami T. .
JOURNAL OF THYROID RESEARCH, 2011, 2011
[5]
Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies [J].
Kadiyala, R. ;
Peter, R. ;
Okosieme, O. E. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (08) :1130-1139
[6]
Neves Celestino, 2008, Rev Port Cardiol, V27, P1211
[7]
VALUE OF BASELINE SERUM THYROTROPIN AS A PREDICTOR OF HYPOTHYROIDISM IN PATIENTS WITH DIABETES MELLITUS [J].
Ramasamy, Vijay ;
Kadiyala, Raghu ;
Fayyaz, Faisal ;
Mallipedhi, Akhila ;
Baglioni, Piero ;
Okosieme, Onyebuchi E. .
ENDOCRINE PRACTICE, 2011, 17 (01) :26-32
[8]
Thyroid hormone replacement for subclinical hypothyroidism [J].
Villar, H. C. C. E. ;
Saconato, H. ;
Valente, O. ;
Atallah, A. N. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03)
[9]
The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies [J].
von Elm, Erik ;
Altman, Douglas G. ;
Egger, Matthias ;
Pocock, Stuart J. ;
Gotzsche, Peter C. ;
Vandenbroucke, Jan P. .
GACETA SANITARIA, 2008, 22 (02) :144-150
[10]
Whitehead C, 2010, PRACTICAL DIABETES I, V27, P113